MINI FUTURE LONG - CATALENT | Market Closed - Bid/Ask 07:07:59 20/05/2024 BST | Pre-market 07:25:03 | |||
| 0.93 EUR | +1.09% |
|
0.945 | +1.61% |
| Current month | -8.91% | ||
| 1 month | -11.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
CATALENT, INC.
| Date | Price | Change |
|---|---|---|
| 20/05/24 | 0.93 | +1.09% |
| 17/05/24 | 0.92 | -1.08% |
| 16/05/24 | 0.93 | -3.12% |
| 15/05/24 | 0.96 | 0.00% |
| 14/05/24 | 0.96 | -2.04% |
Delayed Quote Börse Stuttgart
Last update May 20, 2024 at 07:07 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | CATALENT, INC. |
| Issuer | 
BNP Paribas
|
| WKN | PC6FFU |
| ISIN | DE000PC6FFU1 |
| Date issued | 12/03/2024 |
| Strike | 45.77 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.06 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.14 € |
|---|---|
| Lowest since issue | 0.91 € |
| Spread | 0.06 € |
| Spread % | 6.06% |
Company Profile
Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows:
- provision of development services and clinical supply services (55.4%);
- subcontracted manufacturing services (44.6%).
Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).
Sector
-
Consensus: Catalent, Inc.
Sell
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
55.37
USD
Average target price
63.5
USD
Spread / Average Target
+14.68%
- Stock Market
- Certificates
- Certificat
